We are live on ! Find out more
MGNX icon

MacroGenics

124 hedge funds and large institutions have $495M invested in MacroGenics in 2019 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 53 increasing their positions, 32 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

355% more call options, than puts

Call options by funds: $6.28M | Put options by funds: $1.38M

66% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 32

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

10% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 21

2.13% less ownership

Funds ownership: 95.04%92.91% (-2.1%)

2% less funds holding

Funds holding: 127124 (-3)

17% less capital invested

Capital invested by funds: $593M → $495M (-$98M)

Holders
124
Holders Change
-3
Holders Change %
-2.36%
% of All Funds
2.44%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
19
Increased
53
Reduced
32
Closed
21
Calls
$6.28M
Puts
$1.38M
Net Calls
+$4.9M
Net Calls Change
-$1.58M
Name Holding Trade Value Shares
Change
Change in
Stake
Charles Schwab
26
Charles Schwab
California
$3.26M +$55.7K +5,625 +2%
Macquarie Group
27
Macquarie Group
Australia
$2.99M
Principal Financial Group
28
Principal Financial Group
Iowa
$2.94M +$503K +50,783 +23%
Citadel Advisors
29
Citadel Advisors
Florida
$2.71M -$1.47M -148,802 -37%
RSCM
30
Rock Springs Capital Management
Maryland
$2.5M -$693K -70,000 -23%
Deutsche Bank
31
Deutsche Bank
Germany
$2.5M +$792K +79,972 +53%
GIM
32
Granahan Investment Management
Massachusetts
$2.46M +$16.8K +1,695 +0.8%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$2.3M +$219K +22,136 +12%
OM
34
Opaleye Management
Massachusetts
$2.18M +$1.98M +200,500 New
Two Sigma Advisers
35
Two Sigma Advisers
New York
$2.12M +$1.93M +195,100 New
Axa
36
Axa
France
$1.92M
Man Group
37
Man Group
United Kingdom
$1.67M +$109K +11,000 +8%
DCM
38
DAFNA Capital Management
California
$1.63M -$495K -50,000 -25%
BIM
39
Bogle Investment Management
Massachusetts
$1.63M +$1.48M +149,539 New
Goldman Sachs
40
Goldman Sachs
New York
$1.57M +$112K +11,337 +9%
OAM
41
Oxford Asset Management
United Kingdom
$1.55M +$876K +88,515 +164%
Two Sigma Investments
42
Two Sigma Investments
New York
$1.44M +$1.31M +132,108 New
Massachusetts Financial Services
43
Massachusetts Financial Services
Massachusetts
$1.41M -$139K -14,011 -10%
ECM
44
Endurant Capital Management
California
$1.34M +$1.22M +122,900 New
EP
45
Eversept Partners
New York
$1.27M -$374K -37,826 -24%
California Public Employees Retirement System
46
California Public Employees Retirement System
California
$1.2M +$147K +14,800 +16%
AA
47
ALPS Advisors
Colorado
$1.08M +$18K +1,815 +2%
Swiss National Bank
48
Swiss National Bank
Switzerland
$967K +$26.7K +2,700 +3%
Morgan Stanley
49
Morgan Stanley
New York
$928K +$292K +29,537 +53%
GCP
50
GSA Capital Partners
United Kingdom
$912K +$489K +49,400 +143%

MGNX Hedge Fund Activity: Q4 2019 in Review

124 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q4 2019, worth a combined $495M — down 17% from $593M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of MGNX and 19 opened new positions — a net loss of 2 holders — while 32 trimmed existing stakes and 53 added.

The largest buyer was Wasatch Advisors, adding an estimated $7.85M. The largest seller was GMT Capital, cutting an estimated $10M.

  • 124 institutional investors held MacroGenics (MGNX) as of Q4 2019, down from 127 in Q3 2019.
  • Funds reported $495M of MacroGenics stock for Q4 2019, down 17% quarter-over-quarter.
  • 19 funds opened new MacroGenics positions in Q4 2019 and 21 closed out, a net change of -2 holders.
  • The largest MacroGenics buyer in Q4 2019 was Wasatch Advisors, an estimated $7.85M added.
  • The largest MacroGenics seller in Q4 2019 was GMT Capital, an estimated $10M sold.

Based on aggregated 13F filings for Q4 2019.